基于聚氨酸的共聚合物自组装,具有酸性激活的结构转变,可以感知和缓解败血症
Qilong Wu1,2, Chao Fang2,3, Taixia Wang4
1Department of Ultrasound Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Regenerative biomaterials
|October 29, 2025
概括
一种新型的酸性激活共聚物,PPDD,通过中和活性氧物种,减少炎症和消除细菌,有效地对抗败血症. 这种创新的败血症治疗显著提高了生存率,并显示出有前途的翻译潜力.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 免疫学 免疫学 免疫学
背景情况:
- 败血症是一种危及生命的疾病,由于有效治疗方法有限,死亡率高.
- 目前的干预措施很难解决涉及细菌感染,炎症和氧化应激的复杂病原性.
研究的目的:
- 开发一种基于酸性激活聚氨酸 (PLL) 的共聚合物自组装剂 (PPDD) 用于败血症治疗.
- 研究PPDD在减轻细菌感染,炎症和败血症中氧化应激的疗效.
主要方法:
- 通过将PEG-PLL与DCFH-DA结合合成PPDD.
- 在体外和体外评估PPDD的抗菌,抗氧化和抗炎性质.
- 评估了PPDD在酸性环境中的结构转变及其对治疗效果的影响.
- 在治疗后监测败血症进展和生理参数.
主要成果:
- PPDD显示出快速的ROS中和,显著减少促炎性细胞因子 (TNF-α,IL-6,IL-10) 和有效的细菌清除.
- 在PPDD治疗组中,14日生存率达到80%,而对照组中为20%.
- 酸性激活的PPDD结构重构增强了ROS清除和治疗疗效.
- 生物安全测定没有显示出血解或器官毒性.
结论:
- PPDD是一种生物相容,对酸度有反应的材料,具有用于败血症诊断和治疗的巨大潜力.
- 开发的PPDD平台提供了一个有前途的治疗策略,以改善败血症患者的治疗结果.
- 进一步的临床转化得到了证明的疗效和安全性资料的支持.
相关概念视频
Glycosaminoglycans
6.4K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
6.4K
Structure and Function of Platelets
7.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
7.1K
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Coagulation
8.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Protein Buffers in Blood Plasma and Cells
3.9K
The human body utilizes protein buffer systems to maintain a stable pH. These systems capitalize on the dual role of amino acids, which can act as acids or bases by accepting or releasing hydrogen ions in response to pH changes. Protein buffer systems are particularly significant in the extracellular fluid (ECF) and intracellular fluid (ICF) of active cells, where structural and functional proteins provide substantial buffering capacity.
Certain amino acids can exist in a zwitterion state at a...
Certain amino acids can exist in a zwitterion state at a...
3.9K


